Connect with us
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS...
The global acne treatment market was valued at USD 9,661 million in 2022 and is estimated to reach around USD 15,183.2 million by 2032, poised to...
HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS PR Newswire SAN DIEGO, Aug. 8, 2023 Revenue Increased 45% YOY to $221.0 million; GAAP Diluted EPS of...
KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY PR Newswire...
Acasti Pharma Reports Fiscal Year 2023 Operational Results PR Newswire LAVAL, Québec, June 23, 2023 LAVAL, Québec, June 23, 2023 /PRNewswire/ -- Acasti Pharma Inc....
Calgary, Alberta – TheNewswire - June 20, 2023 - Ocumetics Technology Corp. (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) (“Ocumetics” or the “Company”)...
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"),...
Dean Burns, a 27-year Alcon Vision veteran, will lead Ocumetics through the clinical trial and commercialization process Calgary, Alberta –...
Both Companies Anticipates Approval to Launch of Human Clinical TrialsTel Aviv, Israel and Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - Therma Bright...
Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall...
